Zisková marže společnosti Midatech Pharma Plc
Jaká je hodnota metriky Zisková marže společnosti Midatech Pharma Plc?
Hodnota metriky Zisková marže společnosti Midatech Pharma Plc je -1,095.85%
Jaká je definice metriky Zisková marže?
Zisková marže (Profit margin) je procento čistého zisku z celkových tržeb.
Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.
Zisková marže společností v sektoru Health Care sektor na LSE ve srovnání se společností Midatech Pharma Plc
Čemu se věnuje společnost Midatech Pharma Plc?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Firmy s metrikou zisková marže podobnou společnosti Midatech Pharma Plc
- Hodnota metriky Zisková marže společnosti Tempo Australia je -1,112.63%
- Hodnota metriky Zisková marže společnosti Immutep je -1,112.50%
- Hodnota metriky Zisková marže společnosti Rollatainers je -1,108.02%
- Hodnota metriky Zisková marže společnosti Asia Resources je -1,107.88%
- Hodnota metriky Zisková marže společnosti RedFlow je -1,101.61%
- Hodnota metriky Zisková marže společnosti Cellectis SA je -1,099.67%
- Hodnota metriky Zisková marže společnosti Midatech Pharma Plc je -1,095.85%
- Hodnota metriky Zisková marže společnosti Phunware Inc je -1,092.40%
- Hodnota metriky Zisková marže společnosti Mesoblast je -1,091.87%
- Hodnota metriky Zisková marže společnosti Geomega Resources je -1,090.91%
- Hodnota metriky Zisková marže společnosti Sunwah Kingsway Capital je -1,090.28%
- Hodnota metriky Zisková marže společnosti Arcimoto je -1,084.39%
- Hodnota metriky Zisková marže společnosti Neovasc je -1,081.36%